CD40LG and infection: During the more advanced (8 month) stage of infection, IGHV3 (57.10% in PBMC, 59.31% in BM IgM libraries) and IGHV1 (53.03% in PBMC and 46.29% in BM IgG libraries) were the most dominant while IGHV4 and IGHV1 (respectively, 17.18% in PBMC and 15.98% in BM IgM libraries), and IGHV3 (22.96% in PBMC, 29.15% in BM IgG libraries) were the second most dominant (63).